Enterprise Value
-24.23M
Cash
120.5M
Avg Qtr Burn
-7.528M
Short % of Float
0.66%
Insider Ownership
0.44%
Institutional Own.
91.76%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Tildacerfont Details Congenital adrenal hyperplasia, Primary biliary cholangitis, Liver disease Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 2 Data readout | |
Phase 2 Data readout | ||
Tildacerfont Details Polycystic ovary syndrome | Phase 2 Data readout |